This is the first attempt to systematically record haematological malignancies in Northern Ireland. The methods are identical to a similar effort in other parts of the UK,' except that an independent cross check with a cancer registry source was not possible. In addition problems with the census may create differences. Generally, the rates for the leukaemias are slightly lower than in England and Wales, except for acute lymphoblastic leukaemia whilst non-Hodgkin's lymphoma rates are higher. It remains to be seen how stable this situation is as further data are accumulated.
INTRODUCTION
The Northern Ireland Leukaemia Research Fund Data Collection Study started in 1989 as an independent collection system. At that time there was no Health Service cancer registration scheme in Northern Ireland. The aim was to give an accurate picture of the descriptive epidemiology of haematological malignancies in Northern Ireland. The data come from a special collection of material from the diagnostic laboratories of collaborating haematologists and histopathologists around the province. The method ofcollection was the same as that used in parts of Great Britain.' A previously published study in Northern Ireland2 (the Podar report) concentrated on those leukaemias which are associated with ionising radiation, and used several incomplete registration sources to retrospectively obtain incident cases. Using these data, variations in the incidence of disease by age, sex and area can be described. This is of intrinsic interest and may also be of value in generating hypotheses about the causes of the diseases studied. Incidence rather than death certificate data are used because there is concern over both the accuracy of death certificates and their validity as a measure of disease incidence. Therapeutic advances have led to marked changes in the survival pattern of both leukaemias and lymphomas, with greater survival rates leading to marked decline in mortality. 3 Death certificates were used in the Podar report2 to examine mortality in the leukaemias linked with ionising radiation.
METHODS: Background
Seven disease groupings were used, namely:-(1) Acute Myeloid Leukaemia (AML), (2) Chronic Myeloid Leukaemia (CML), (3) Myelodysplasia (MDS), (4) Acute Lymphoblastic Leukaemia (ALL), (5) Non-Hodgkin's Lymphoma (NHL), (6) Hodgkin's disease (HD), and (7) Multiple Myeloma (MM). These groupings were chosen because they provided sufficient numbers of cases for a critical statistical analysis. Incidence data are reported in 5-year age groups up to 79 years.4 In common with the GB Leukaemia Research Fund atlas,' no incidence data on the over 80's are reported because of lack of diagnostic accuracy and ascertainment problems. Further detail is given in the full report.4
Local government district populations from the 1991 census were used in the analysis. 5 Age-specific incidence rates and uniformn standardised incidence rates (per 100,000 person years) by disease grouping, pooled over both sexes. The number of cases is in parentheses. A compromise is an "empirical Bayes") version of the SMR.8 A probability model is adopted for the prior distribution of the true relative risks across the map. The influence of this model upon the estimation ofthe relative risks follows from "Bayes theorem"". The method for estimating the parameters of this prior distribution is termed the "empirical Bayes" method Two types of map are illustrated in the full report.4 Both use "empirical Bayes" methods. 8 The first is a map of relative risk (RR) estimates which lie intermediate between the area-specific SMR and the mean of all the age-adjusted relative risks included in the map. Estimates are shrunk towards the mean; this shrinkage is substantial for RR's based upon small numbers of events while those based upon large numbers remain close to the corresponding SMR' s. Using small areas, this approach may be modified so that shrinkage is towards a "local" mean based upon adjacent areas, and this method was used in the second map. 4 Comprehensive results are given in the full report.4 GENSTAT V was used to carry out all analyses.9 RESULTS AND DISCUSSION ACUTE MYELOID LEUKAEMIA There were 147 cases. Age-specific incidence rates show higher rates in the first five years, followed by a decline (Table I ). The pooled rates do not exceed those observed in cases aged 0-4 years until the 40's. There is a female excess in those aged 5-35 years roughly similar rates in both sexes between 35 and 55 yrs and a male predominance emerges in the over 55's. There is no evidence for a temporal trend. There is no evidence for between-district heterogeneity in the SMR' s (Table II) . There is not much variation in the "shrunk" RR's. However, for the adjacency smoothed RR's, the highest rates tend to be concentrated in the South East of the province, particularly in the County Down area, Belfast Lough and the Mourne mountains. The lowest rates occur in the north of the province, and County Fermanagh.
CHRONIC MYELOID LEUKAEMIA There were 35 cases. Age-specific incidence rates (Table I) The Ulster Medlic(al JoItI-)l(ll (Table II) .
Since there is a significant statistical interaction between sex and geographical distribution at district level, the maps of pooled rates may not be meaningful. Also, because there may be an interaction between age and geographical distribution, the male and female maps have to be treated with caution. (Accordingly, we only illustrate maps of male rates). These maps of male rates are illustrated (Maps I & 2) and show highest rates in the South West, particularly in County Fermanagh, and south of Lough Neagh, but also around Belfast Lough. Lowest rates are seen in the North and West of the province.
NON-HODGKIN'S LYMPHOMA
The study reports on 6 11 cases. Incidence is low in children but the incidence rates rise steeply from early adult life (Table I) . There is a suggestion of an adolescent peak in males. There is a male excess at most ages. There is no evidence of an increase over time. Surprisingly, in view of English data suggesting the reverse (McNally et al -unpublished observations) there is some suggestion of a male decrease (p=0.036) over time.
There is no evidence for between-district heterogeneity in the SMR's (Table II) There is no evidence for between-district heterogeneity in the SMR's (Table II) . However, Ballymoney appears to have a raised SMR for females (p=0.04). There is not much variability in (Figure 2 and Table I ). There is evidence for an increase in the male rates (p=0.0 1), but the female rates were stable over the 5 year period (Table III) .
There is a problem with under-registration of multiple myeloma, and so incidence rates are likely to be underestimates of the true rates.
There is no evidence for between-district heterogeneity from either the pooled or male SMR' s. However, there is some evidence (p=0.083) of heterogeneity amongst the female SMR's. Ards has a raised pooled SMR (p=0.01 - Table II We wish to record that material in this publication has been produced using data relating to digitized boundary information which remains the property and copyright of the Crown. The 1991 Census data are Crown copyright, from the ESRC purchase.
